129 related articles for article (PubMed ID: 38171241)
1. Docetaxel administered through a novel lymphatic drug delivery system (LDDS) improved treatment outcomes for lymph node metastasis.
Sukhbaatar A; Mori S; Sugiura T; Kodama T
Biomed Pharmacother; 2024 Feb; 171():116085. PubMed ID: 38171241
[TBL] [Abstract][Full Text] [Related]
2. Intranodal delivery of modified docetaxel: Innovative therapeutic method to inhibit tumor cell growth in lymph nodes.
Sukhbaatar A; Mori S; Kodama T
Cancer Sci; 2022 Apr; 113(4):1125-1139. PubMed ID: 35100484
[TBL] [Abstract][Full Text] [Related]
3. Intranodal pressure of a metastatic lymph node reflects the response to lymphatic drug delivery system.
Kato S; Takeda K; Sukhbaatar A; Sakamoto M; Mori S; Shiga K; Kodama T
Cancer Sci; 2020 Nov; 111(11):4232-4241. PubMed ID: 32882076
[TBL] [Abstract][Full Text] [Related]
4. Study of the physicochemical properties of drugs suitable for administration using a lymphatic drug delivery system.
Fukumura R; Sukhbaatar A; Mishra R; Sakamoto M; Mori S; Kodama T
Cancer Sci; 2021 May; 112(5):1735-1745. PubMed ID: 33629407
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy of lymphatic drug delivery and total body irradiation in a metastatic lymph node and lung mouse model.
Sora S; Sukhbaatar A; Fukushige S; Mori S; Sakamoto M; Kodama T
Cancer Sci; 2023 Jan; 114(1):227-235. PubMed ID: 36056924
[TBL] [Abstract][Full Text] [Related]
6. Treatment of false-negative metastatic lymph nodes by a lymphatic drug delivery system with 5-fluorouracil.
Fujii H; Horie S; Sukhbaatar A; Mishra R; Sakamoto M; Mori S; Kodama T
Cancer Med; 2019 May; 8(5):2241-2251. PubMed ID: 30945479
[TBL] [Abstract][Full Text] [Related]
7. Protocols for the Evaluation of a Lymphatic Drug Delivery System Combined with Bioluminescence to Treat Metastatic Lymph Nodes.
Sukhbaatar A; Kodama T
Methods Mol Biol; 2022; 2524():333-346. PubMed ID: 35821485
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of cisplatin given with a lymphatic drug delivery system on false-negative metastatic lymph nodes.
Tada A; Horie S; Mori S; Kodama T
Cancer Sci; 2017 Nov; 108(11):2115-2121. PubMed ID: 28846190
[TBL] [Abstract][Full Text] [Related]
9. Intralymphatic injection of chemotherapy drugs modulated with glucose improves their anticancer effect.
Sukhbaatar A; Mori S; Shiga K; Kodama T
Biomed Pharmacother; 2023 Sep; 165():115110. PubMed ID: 37421779
[TBL] [Abstract][Full Text] [Related]
10. Optimal range of injection rates for a lymphatic drug delivery system.
Fujii H; Horie S; Takeda K; Mori S; Kodama T
J Biophotonics; 2018 Aug; 11(8):e201700401. PubMed ID: 29461015
[TBL] [Abstract][Full Text] [Related]
11. Optimization of the delivery of molecules into lymph nodes using a lymphatic drug delivery system with ultrasound.
Kato S; Yoshiba S; Mori S; Kodama T
Int J Pharm; 2021 Mar; 597():120324. PubMed ID: 33540016
[TBL] [Abstract][Full Text] [Related]
12. Drug formulation augments the therapeutic response of carboplatin administered through a lymphatic drug delivery system.
Mishra R; Sukhbaatar A; Dorai A; Mori S; Shiga K; Kodama T
Cancer Sci; 2023 Jan; 114(1):259-270. PubMed ID: 36168838
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic mapping of mice with systemic lymphoproliferative disorder: usefulness as an inter-lymph node metastasis model of cancer.
Shao L; Mori S; Yagishita Y; Okuno T; Hatakeyama Y; Sato T; Kodama T
J Immunol Methods; 2013 Mar; 389(1-2):69-78. PubMed ID: 23328410
[TBL] [Abstract][Full Text] [Related]
14. Metastatic lymph node targeted CTLA4 blockade: a potent intervention for local and distant metastases with minimal ICI-induced pneumonia.
Mishra R; Sukhbaatar A; Mori S; Kodama T
J Exp Clin Cancer Res; 2023 Jun; 42(1):132. PubMed ID: 37259163
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the enhanced permeability and retention effect in the early stages of lymph node metastasis.
Mikada M; Sukhbaatar A; Miura Y; Horie S; Sakamoto M; Mori S; Kodama T
Cancer Sci; 2017 May; 108(5):846-852. PubMed ID: 28211204
[TBL] [Abstract][Full Text] [Related]
16. Delivery of molecules to the lymph node via lymphatic vessels using ultrasound and nano/microbubbles.
Kato S; Shirai Y; Kanzaki H; Sakamoto M; Mori S; Kodama T
Ultrasound Med Biol; 2015 May; 41(5):1411-21. PubMed ID: 25637527
[TBL] [Abstract][Full Text] [Related]
17. Use of a Lymphatic Drug Delivery System and Sonoporation to Target Malignant Metastatic Breast Cancer Cells Proliferating in the Marginal Sinuses.
Kato S; Shirai Y; Sakamoto M; Mori S; Kodama T
Sci Rep; 2019 Sep; 9(1):13242. PubMed ID: 31519920
[TBL] [Abstract][Full Text] [Related]
18. Lymph node resection induces the activation of tumor cells in the lungs.
Sukhbaatar A; Mori S; Saiki Y; Takahashi T; Horii A; Kodama T
Cancer Sci; 2019 Feb; 110(2):509-518. PubMed ID: 30499190
[TBL] [Abstract][Full Text] [Related]
19. New concept for the prevention and treatment of metastatic lymph nodes using chemotherapy administered via the lymphatic network.
Kodama T; Matsuki D; Tada A; Takeda K; Mori S
Sci Rep; 2016 Sep; 6():32506. PubMed ID: 27581921
[TBL] [Abstract][Full Text] [Related]
20. Imaging of the Mouse Lymphatic Sinus during Early Stage Lymph Node Metastasis Using Intranodal Lymphangiography with X-ray Micro-computed Tomography.
Iwamura R; Sakamoto M; Mori S; Kodama T
Mol Imaging Biol; 2019 Oct; 21(5):825-834. PubMed ID: 30607526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
